Galapagos Corp (GLPG) Cash Money per Share

Galapagos NV - graphic logo of issuer GLPG

Galapagos NV leverages its strong scientific human capital to support an ambitious R&D pipeline transformation toward decentralized CAR-T therapy. The estimated cash per share on GURU.Markets reflects the current liquidity reserve, with the current mark standing at 53.60. This ensures the financial stability required to implement unique bedside drug manufacturing, granting the company significant pricing power.

Galapagos (GLPG): Cash per Share from 07/04/2022 to 05/08/2026

Analytical breakdowns for Galapagos NV

- price and consensus price forecast:
- cash availability and cash flow indicators:
General company analysis:Galapagos Corp - GLPG
Original product of Galapagos

The development of a decentralized CAR-T therapy network requires significant expenditures to integrate scientific discoveries into clinical practice. Analyzing the cash per share, an investor sees the current value of 53.60, which reflects the portion of liquid assets per share; this indicator allows for an assessment of the financial stability of Galapagos NV (GLPG) and the risk of business degradation in the event of a working capital deficit.

Analysis of competing companies

Cash on Hand per Share Haleon Corp HLN|Cash per Single Share KVUE (Kenvue Health)|Verona Pharma plc - Cash Funds per Single Share|Jyong Biotech - Cash per Single Share|LGND: Cash Funds per Single Share|AMRX: Cash per Single Share|Cash on Hand per Share Perrigo Company plc|ALVO: Cash per Share|Liquidia (LQDA) - Cash per Share|Cash Funds per Share ANI Pharmaceuticals Inc|MNKD: Amount of Cash per Share|Cash per Single Share AMPH (Amphastar)|PCRX - Cash on Hand per Share|Cash per Share SPRY (ars-pharma.com)|Amount of Cash per Share TBPH|Aquestive Therapeutics, Inc. - Cash per Share|scpharmaceuticals.com - Cash Calculated per Single Share|Tectonic (TECX) - Cash Funds per Share|Cash per Single Share Tonix Pharmaceuticals Inc.|Cash Funds per Share sxtchina.com|Cash per Single Share Eupraxia Pharmaceuticals (EPRX)|Cash per Share BHST|EXOZ - Cash on Hand per Share|Oramed - Cash per Single Share|Entera Bio Ltd. (ENTX) - Cash on Hand per Share|HYFT - Cash Funds per Share|ABVC: Cash Funds per Share|CPIX: Cash per Share|Quantum BioPharma Ltd. - Amount of Cash per Share|FGEN (FibroGen Corp) - Cash per Share|Telomir Pharma (TELO) - Cash Funds Calculated per Share|Cash Funds per Share Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Amount of Cash per Share|Cash Funds per Share Rallybio Corporation RLYB|LEXX: Cash Funds per Single Share|PULM - Cash Funds per Share|Amount of Cash per Share PTHL (Pheton Holdings)|Aptorum (APM) - Cash Funds per Share|LYRA (Lyra Therapeutics) - Cash Funds per Share|Cash Funds per Share Impact BioMedical Inc|TNF Pharmaceuticals - Cash Money per Share|Cash per Share YCBD|Cash per Share PainReform Ltd. (PRFX)|Cash Funds per Share Altamira Therapeutics Ltd CYTO|LIPO (lipella.com) - Cash Money per Share|OptiNose - Cash per Share|Cash Money per Share PIRS|PROC: Cash per Share|Petros - Amount of Cash per Share|Cash per Single Share QLI|SLRN: Amount of Cash per Share|Cash per Single Share TFFP (TFF Pharmaceuticals, Inc.)